Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
ICYMI: A Push for Affordable Prices for Taxpayer-Funded Drugs
‘Paying Twice’: A Push for Affordble Prices for Taxpayer-Funded Drugs Robert Pear // The New York Times // May 28, 2018 KEY POINT “We have an incredibly powerful, incredibly productive research and development program being run by N.I.H.,” Ameet Sarpatwari, an instructor at Harvard Medical School, said. “Taxpayers put in money that is paying big […]
News and Reports
PBS NewsHour: Will Trump’s drug prices plan make a difference for patients?
President Trump unveiled his plan for lowering prescription drug prices in a speech on Friday, in which he railed against the “very, very rich” middlemen and assured the American people of “tougher negotiation, more competition and much lower prices at the pharmacy counter.” David Mitchell, a cancer patient and the president of Patients For Affordable […]
News and Reports
MLex Market Insight: How Celgene Uses Safety Concerns to Keep Its $7 Billion Cancer Drug on Top
January 12 Leah Nylen Pam Holt, a retired teacher in Grainger, Indiana, was diagnosed with cancer in 2014. At the time, her treatment — with a derivative of the once-banned sedative thalidomide — cost $588 a month. In the past few months, her share of the bill has risen to $640 a month. “I do […]
News and Reports
New York Times: Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.
January 6 Danny Hakim Humira is the best-selling prescription drug in the world. You may have seen the commercials. Because of Humira, a woman with rheumatoid arthritis can wash her puppy in the bathtub, another with colitis can stroll happily through a fair packed with food vendors, while a third suffering from psoriasis can go […]
News and Reports
January 1 JC Reindl We are still losing the battle to contain fast-rising drug prices in Michigan and across the country, but increased scrutiny of pricey pharmaceuticals led to some minor victories in 2017 for more affordable health care, according to several of Michigan’s larger insurers. Prices for many popular branded drugs that made big […]
News and Reports
STAT: Trump proposal to lower drug prices targets insurer, PBM rebates
November 17 Erin Mershon The Trump administration is exploring policy changes that could eventually lower the prices Medicare beneficiaries pay at the pharmacy counter. Although it’s only a small, initial step in that direction, it’s one of the first signals of how the Trump administration is trying to deliver on the president’s promises to lower […]
News and Reports
STAT: Allergan invokes the victim defense to protect a brand-name drug from a generic challenge
November 3 David Mitchell Allergan, a multibillion-dollar drug corporation, is attempting to perpetrate a fraud on the American people that would make Bernie Madoff blush — even as it casts itself as a victim. Allergan makes several products, including Restasis, a very expensive brand-name drug that people with dry eye and related conditions take to […]
News and Reports
KelloggInsight: Prescription Drug Coupons Actually Increase Healthcare Spending by Billions
October 3 Based on the research of Leemore Dafny, Christopher Ody and Matt Schmitt Last year, the pharmaceutical company Mylan faced public outcry when it raised the price of the lifesaving allergy medication EpiPen to $609 a box. In response to the furor, Mylan pointed out it offers copay coupons that can reduce consumers’ out-of-pocket […]